Abdulrahman Alsuhibani, Pharm.D, MSc.

PhD Student
James L. Winkle College of Pharmacy, University Of Cincinnati

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Poster(s):

• (P-200) Safety Evaluation of Panobinostat, Ixazomib, Elotuzumab, and Daratumumab Using FDA Adverse Event Reporting System (FAERS) Database 2015 – 2020

• (P-201) Comparison of Quality of Life Between Men and Women with Chronic Liver Diseases Using Chronic Liver Disease Questionnaire (CLDQ): A Meta-analysis